BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE
Described herein are benzoxazepin oxazolidinone compounds with phosphoinositide- 3 kinase (PI3K) modulation activity or function having the Formula (I) structure: or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described he...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MACLEOD, CALUM BRAUN, MARIE-GABRIELLE ELLIOTT, RICHARD HANAN, EMILY HEALD, ROBERT ANDREW STABEN, STEVEN T |
| description | Described herein are benzoxazepin oxazolidinone compounds with phosphoinositide- 3 kinase (PI3K) modulation activity or function having the Formula (I) structure: or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the Formula I compounds, as well as methods of using such PI3K modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon PI3K dysregulation.
L'invention concerne des composés de benzoxazépine oxazolidinone doués d'une activité ou d'une fonction de modulation de la phosphoinositide 3-kinase (PI3K) ayant une structure selon la Formule (I) : ou les stéréoisomères, tautomères ou sels pharmaceutiquement acceptables de ceux-ci, leurs substituants et caractéristiques structurales étant tels que définis dans la description. Des compositions pharmaceutiques et des médicaments contenant lesdits composés de Formule I, ainsi que des méthodes d'utilisation desdits modulateurs de PI3K, seuls ou en association avec d'autres agents thérapeutiques, dans le traitement de maladies ou d'affections qui sont médiées par une dérégulation de PI3K ou qui en dépendent sont en outre décrits. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2982708C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2982708C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2982708C3</originalsourceid><addsrcrecordid>eNrjZDB3cvWL8o9wjHIN8PRTADH8fTxdPP38_VwVnP19A_xD_VyCFRz9XBR8XUM8_IFsfzeF0GBXHgbWtMSc4lReKM3NIO_mGuLsoZtakB-fWlyQmJyal1oS7-xoZGlhZG5g4WxMWAUAzpsnrQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE</title><source>esp@cenet</source><creator>MACLEOD, CALUM ; BRAUN, MARIE-GABRIELLE ; ELLIOTT, RICHARD ; HANAN, EMILY ; HEALD, ROBERT ANDREW ; STABEN, STEVEN T</creator><creatorcontrib>MACLEOD, CALUM ; BRAUN, MARIE-GABRIELLE ; ELLIOTT, RICHARD ; HANAN, EMILY ; HEALD, ROBERT ANDREW ; STABEN, STEVEN T</creatorcontrib><description>Described herein are benzoxazepin oxazolidinone compounds with phosphoinositide- 3 kinase (PI3K) modulation activity or function having the Formula (I) structure: or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the Formula I compounds, as well as methods of using such PI3K modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon PI3K dysregulation.
L'invention concerne des composés de benzoxazépine oxazolidinone doués d'une activité ou d'une fonction de modulation de la phosphoinositide 3-kinase (PI3K) ayant une structure selon la Formule (I) : ou les stéréoisomères, tautomères ou sels pharmaceutiquement acceptables de ceux-ci, leurs substituants et caractéristiques structurales étant tels que définis dans la description. Des compositions pharmaceutiques et des médicaments contenant lesdits composés de Formule I, ainsi que des méthodes d'utilisation desdits modulateurs de PI3K, seuls ou en association avec d'autres agents thérapeutiques, dans le traitement de maladies ou d'affections qui sont médiées par une dérégulation de PI3K ou qui en dépendent sont en outre décrits.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231003&DB=EPODOC&CC=CA&NR=2982708C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231003&DB=EPODOC&CC=CA&NR=2982708C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MACLEOD, CALUM</creatorcontrib><creatorcontrib>BRAUN, MARIE-GABRIELLE</creatorcontrib><creatorcontrib>ELLIOTT, RICHARD</creatorcontrib><creatorcontrib>HANAN, EMILY</creatorcontrib><creatorcontrib>HEALD, ROBERT ANDREW</creatorcontrib><creatorcontrib>STABEN, STEVEN T</creatorcontrib><title>BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE</title><description>Described herein are benzoxazepin oxazolidinone compounds with phosphoinositide- 3 kinase (PI3K) modulation activity or function having the Formula (I) structure: or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the Formula I compounds, as well as methods of using such PI3K modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon PI3K dysregulation.
L'invention concerne des composés de benzoxazépine oxazolidinone doués d'une activité ou d'une fonction de modulation de la phosphoinositide 3-kinase (PI3K) ayant une structure selon la Formule (I) : ou les stéréoisomères, tautomères ou sels pharmaceutiquement acceptables de ceux-ci, leurs substituants et caractéristiques structurales étant tels que définis dans la description. Des compositions pharmaceutiques et des médicaments contenant lesdits composés de Formule I, ainsi que des méthodes d'utilisation desdits modulateurs de PI3K, seuls ou en association avec d'autres agents thérapeutiques, dans le traitement de maladies ou d'affections qui sont médiées par une dérégulation de PI3K ou qui en dépendent sont en outre décrits.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB3cvWL8o9wjHIN8PRTADH8fTxdPP38_VwVnP19A_xD_VyCFRz9XBR8XUM8_IFsfzeF0GBXHgbWtMSc4lReKM3NIO_mGuLsoZtakB-fWlyQmJyal1oS7-xoZGlhZG5g4WxMWAUAzpsnrQ</recordid><startdate>20231003</startdate><enddate>20231003</enddate><creator>MACLEOD, CALUM</creator><creator>BRAUN, MARIE-GABRIELLE</creator><creator>ELLIOTT, RICHARD</creator><creator>HANAN, EMILY</creator><creator>HEALD, ROBERT ANDREW</creator><creator>STABEN, STEVEN T</creator><scope>EVB</scope></search><sort><creationdate>20231003</creationdate><title>BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE</title><author>MACLEOD, CALUM ; BRAUN, MARIE-GABRIELLE ; ELLIOTT, RICHARD ; HANAN, EMILY ; HEALD, ROBERT ANDREW ; STABEN, STEVEN T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2982708C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MACLEOD, CALUM</creatorcontrib><creatorcontrib>BRAUN, MARIE-GABRIELLE</creatorcontrib><creatorcontrib>ELLIOTT, RICHARD</creatorcontrib><creatorcontrib>HANAN, EMILY</creatorcontrib><creatorcontrib>HEALD, ROBERT ANDREW</creatorcontrib><creatorcontrib>STABEN, STEVEN T</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MACLEOD, CALUM</au><au>BRAUN, MARIE-GABRIELLE</au><au>ELLIOTT, RICHARD</au><au>HANAN, EMILY</au><au>HEALD, ROBERT ANDREW</au><au>STABEN, STEVEN T</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE</title><date>2023-10-03</date><risdate>2023</risdate><abstract>Described herein are benzoxazepin oxazolidinone compounds with phosphoinositide- 3 kinase (PI3K) modulation activity or function having the Formula (I) structure: or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the Formula I compounds, as well as methods of using such PI3K modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon PI3K dysregulation.
L'invention concerne des composés de benzoxazépine oxazolidinone doués d'une activité ou d'une fonction de modulation de la phosphoinositide 3-kinase (PI3K) ayant une structure selon la Formule (I) : ou les stéréoisomères, tautomères ou sels pharmaceutiquement acceptables de ceux-ci, leurs substituants et caractéristiques structurales étant tels que définis dans la description. Des compositions pharmaceutiques et des médicaments contenant lesdits composés de Formule I, ainsi que des méthodes d'utilisation desdits modulateurs de PI3K, seuls ou en association avec d'autres agents thérapeutiques, dans le traitement de maladies ou d'affections qui sont médiées par une dérégulation de PI3K ou qui en dépendent sont en outre décrits.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2982708C |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T13%3A24%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MACLEOD,%20CALUM&rft.date=2023-10-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2982708C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |